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How pathogens exploit interactions mediated 
by SH3 domains 
An important event in signal transduction is the binding of SH3 domains, found in viral 
proteins such as v-Src and v-Crk, to proline-rich sequences. Recently, proline-rich 
proteins that bind host-cell SH3 domains have been identified in a variety of 
pathogenic microorganisms. Exploitation of SH3-mediated interactions 
by pathogens may be more common than previously suspected. 
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The amino-terminal, non-catalytic region of the v-Src 
kinase contains two modular domains, known as Src 
homology region 2 (SH2) and Src homology region 3 
(SH3), that are conserved in a large number of signal 
transduction proteins [1,2]. SH2 domains are - 100 amino 
acids in length and bind to proteins that are phosphory 
lated on tyrosine within a specific consensus motif. SH3 
domains are - 60 amino acids in length and bind to 
sequences that adopt a left-handed polyproline II helical 
structure. Most SH3-binding sequences contain at least 
two prolines and conform to the general consensus motif 
PxxP, where P is proline and x is a non-conserved residue. 
SH2 and SH3 domains can be thought of as modular 
cassettes that are inserted into proteins in different loca- 
tions and in different combinations to promote highly 
specific protein-protein interactions. These domains are 
found in structural proteins, in enzymes (e.g., v-Src) and in 
proteins with no other apparent functional domains.This 
latter class of SH2/SH3-containing proteins function as 
‘adapters’ or ‘molecular adhesives’ that participate in the 
formation of multiprotein complexes [3]. 
Given the importance of SH2 and SH3 domains in 
normal cellular physiology, it is not surprising that patho- 
genic microbes, both viruses and bacteria, have acquired 
these protein modules from their eukaryotic hosts and 
adapted them for their own uses. One of the more inten- 
sively studied viral SH2/SH3-containing proteins is 
v-Crk, originally identified as the oncogenic agent of the 
avian sarcoma virus CT10 [3]. v-Crk mediates CTlO- 
induced tumor formation in chickens, and in cultured 
cells v-Crk induces cellular transformation associated 
with alterations in cell morphology, increased adhesion- 
independent growth, and enhanced tyrosine phosphory- 
lation of several proteins. The name Crk, for CT10 
regulator of kinase, is derived from this latter property. 
Cellular transformation mediated by v-Crk probably 
provides a selective advantage to CT10 by enhancing the 
rate of viral replication. 
More recently, viral proteins that interact with host cell 
SH3 domains via PxxP motifs have been identified. One 
such protein is Nef of HIV-1 [4]. Interaction of Nef with 
host cell SH3 domains seems to enhance HIV-1 infectivity 
through modulation of host cell signaling functions.These 
findings suggest that microbial exploitation of SH3-medi- 
ated interactions may be a widely used infection strategy. 
In the following sections, I will briefly review the molecu- 
lar basis of the interaction of SH3 domains with PxxP 
motifs and then discuss the role of these interactions in 
microbial pathogenesis, focusing primarily on v-Crk and 
recently described viral SH3-binding proteins. 
Molecular basis of SH3 domain-PxxP interactions 
Analysis of the three-dimensional structure of several dif- 
ferent SH3 domains has revealed a common organization 
consisting of two anti-parallel p sheets packed against 
each other to form a shallow peptide-binding surface 
[2,5]. The binding surface is dominated by a patch of 
conserved hydrophobic residues, which is flanked on one 
side by a cluster of charged amino acids formed by the 
variable RT loop (so called because it contains arginine 
and threonine residues that are critical to the function of 
Src) and the variable n-Src loop (which contains an inser- 
tion in the sequence of neuronal Src). The helical struc- 
ture of the bound ligand resembles a trigonal prism, with 
two edges of the prism directly contacting the surface of 
the SH3 domain (Fig. l).The two conserved prolines in 
the PxxP motif form extensive interactions with 
hydrophobic residues in the SH3 domain.Two different 
classes of PxxP motifs have been identified, depending on 
the orientation in which they bind SH3 domains [2,6]. 
Class I motifs bind in the ‘plus’ orientation and generally 
contain charged residues on the amino-terminal side of 
the PxxP motif. Conversely, Class II motifs contain 
charged residues carboxy-terminal to the PxxP motif and 
bind in the opposite, or ‘minus’, orientation. Binding ori- 
entation seems to be determined by electrostatic interac- 
tions between the basic residues that flank the PxxP motif 
and the acidic residues in the RT loop of the SH3 
domain [2,6]. 
Proline-rich peptides generally bind to SH3 domains with 
dissociation constants (I$ values) in the low micromolar 
(PM) range, as determined by fluorescence spectroscopy. 
Binding orientation does not seem to correlate with 
binding affinity, as high and low affinity peptides that bind 
in either orientation have been identified. Certain peptides 
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Fig. 1. Schematic diagram showing interactions between a 
proline-rich peptide from C3G and the c-Crk SH3-N domain. The 
C3G peptide is represented by the left-handed ribbon, and 
peptide residues that interact with the SH3 domain are indicated 
by the shaded circles. Residues in c-Crk SH3-N that interact with 
the peptide are indicated as oval boxes (for hydrophobic 
residues) and rectangular boxes (for acidic residues). Conserved 
prolines in the PxxP motif correspond to Pro3 and Pro6. 
Distances (in A) between interacting residues are shown for the 
nearest pair of carbon atoms (for hydrophobic interactions) and 
between donor atom and acceptor atom for hydrogen bonds. 
Reprinted with permission from [13]. 
bind with high affinity to several different SH3 domains, 
whereas others are more specific. As discussed below, it 
seems that subtle differences in ionic contacts between 
peptides and SH3 domains are critical determinants of 
binding affinity and specificity 
The v-Crk SH3 domain in CT1 O-induced cellular transformation 
v-Crk is a 47-kDa protein consisting of a viral-derived 
Gag (coat protein) sequence followed by a single SH2 
domain and a single SH3 domain [3] (Fig. 2).Three cellu- 
lar homologs of v-Crk have been identified: c-Crk I and 
c-Crk II, which arise from alternatively spliced transcripts, 
and a third distinct protein called Crk-L (for Crk-like 
protein) (Fig. 2). Whereas v-Crk and c-Crk I share a 
similar organization, c-Crk II and c-Crk-L contain a 
carboxy-terminal spacer region followed by an additional 
SH3 domain. Recent evidence suggests that the cellular 
Crk proteins are involved in signal transduction pathways 
dependent on Ras, or Ras-related GTPases [3].Two pro- 
teins that are highly phosphorylated in CTlO-transformed 
cells and that bind the Crk SH2 domain are Cas (Crk- 
associated substrate) and paxillin [3]. Cas and paxillin 
seem to be involved in signaling between extracellular 
matrix receptors and the cytoskeleton [3,7], but a direct 
link between these proteins and Ras-dependent signaling 
pathways remains to be shown. 
The SH3 domain of v-Crk binds in vitro to multiple PxxP- 
containing proteins including the tyrosine kinases Abl and 
Arg, the guanine nucleotide exchange factors (GNEFs) 
SOS and C3G, and the epidermal growth factor receptor 
substrate Epsl5 [3,8]. v-Crk has been shown to bind Abl 
and C3G constitutively in viva. In contrast, binding ofAb1 
to the amino-terminal SH3 domain (SH3-N) of c-Crk II 
(hereafter referred to as c-Crk) seems to be transient, and 
can only be detected in vitro, or when the proteins are 
highly overexpressed in uivo [3,9]. Abl phosphorylates a 
tyrosine (Tyr221) in the spacer region between the SH3 
domains of c-Crk under conditions that favor their inter- 
action [3].This SH3-mediated selection of c-Crk as a sub- 
strate by Abl may be important in negative regulation of 
c-Crk. Intramolecular binding of the c-Crk SH2 domain 
to phosphorylatedTyr221 folds the protein into an inactive 
conformation, sequestering both the SH2 domain and 
the first SH3 domain (SH3-N) from interactions with 
other proteins [3,9,10]. v-Crk lacks this regulatory site of 
phosphorylation and thus may be constitutively active. 
Mutational analysis of CT10 has shown that the SH2 and 
SH3 domains of v-Crk are critical for transforming activity 
[ 11,121. For example, either deletion of the SH3 domain, 
or insertion of a linker mutation into the RT loop was 
associated with a significant reduction or a complete loss in 
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Fig. 2. Structures of wild-type and mutant forms of v-Crk and their 
relationship to cellular Crk proteins. Schematic representations of the 
domains (Gag (viral coat protein), SH2 and SH3) in various Crk pro- 
teins are shown. The ability of wild-type v-Crk or various deletion 
(ASH3), linker insertion (BSP) or chimeric v-Crk proteins to mediate 
CTIO-induced tumor formation in chickens is indicated. Asterisks 
indicate the positions of amino-acid substitutions (Asnl41 +Lys and 
Glu149+Gly) in the v-Crk SH3 domain. Arrowhead indicates the 
position of the linker insertion in the BSP mutant. In c-Crk II, the 
tyrosine (Tyr221) phosphorylated by Abl is shown. 
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viral tumorigenicity (Fig. 2). Replacement of the v-Crk 
SH3 domain with SH3 domains from PLC-y, v-Src or 
c-Src also resulted in a complete loss in tumorigenicity 
(Fig. 2). Surprisingly, a chimera of v-Crk containing the 
SH3-N domain from c-Crk has also been reported to be 
non-tumorigenic [ll]. One explanation for this finding 
may be the fact that the sequence of the v-Crk SH3 
domain differs from that of the c-Crk SH3-N domain at 
two positions.These substitutions lie within the RT loop 
and correspond to conversion of Asn141 to lysine and 
Glu149 to glycine. 
Analysis of the three-dimensional structure of proline-rich 
peptides bound to the c-Crk SH3-N domain has revealed 
that the binding specificity of the Crk SH3-N domain is 
determined by the nature of the ionic contacts formed 
between acidic residues in the RT loop, in particular Glu149, 
and the first basic residue following the PxxP motif [13]. 
Glu149 forms a highly specific interaction with the lysine 
that follows the PxxP motif in a peptide derived from C3G, 
whereas a peptide derived fcom SOS, which contains an argi- 
nine after the PxxP motif, does not form this interaction. 
This may explain why the C3G peptide binds selectively and 
with high affinity to the c-Crk SH3-N domain, whereas the 
SOS peptide binds with somewhat lower but equal affinities 
to the Crk and Grb2 SH3-N domains (Table 1). Because the 
v-Crk SH3 domain contains a glycine at position 149 
instead of glutamic acid, it binds the C3G peptide with lower 
affinity and is not sensitive to the presence of lysine versus 
arginine in peptides (Table l).The loss in SH3-binding selec- 
tivity resulting from this mutation may contribute to the 
oncogenic potential of v-Crk. A model for v-Crk-induced 
tumorigenicity which incorporates these concepts is shown 
in Figure 3. 
Fig. 3. A model for v-Crk-induced cellu- 
lar transformation. v-Crk expressed after 
viral infection binds via SH2 to Cas and 
paxillin molecules that are constitutively 
tyrosine phosphorylated at a low level in 
the host cell. Tyrosine kinases (Abl 
and/or Arg) are then recruited to these 
sites by the v-Crk SH3 domain. 
Hyperphosphorylation of Cas and pax- 
illin results from the processive action of 
Abl and/or Arg, leading to the formation 
of additional v-Crk binding sites. 
Guanine nucleotide exchange factors 
(CNEFs; e.g., SOS and C3G) are then 
recruited to these sites by v-Crk SH3 
domains. The apparent non-selectivity of 
the v-Crk SH3 domain may contribute to 
the recruitment of inappropriate levels 
or types of GNEFs. The focal accumula- 
tion of GNEF activity at the membrane 
leads to the constitutive activation of a 
Ras or Ras-related signaling pathway. 
Table 1. Binding affinities of proline-rich peptides for the SH3 









PPPALPPKKR (C3G) 1.89 c 0.06 25.5 f 0.2 142 + 3 
PPPVPPRRRR (SOS) 5.24 z!z 0.16 23.7 f 0.6 3.54 f 0.16 
Data are from Knudsen et al. [23]. The data shown are for glu- 
tathione S-transferase fusion proteins and were obtained by 
measuring the changes in intrinsic tryptophan fluorescence 
upon peptide binding. Conserved prolines in the PxxP motif 
are indicated in bold. 
Interaction of viral PxxP-containing proteins with host cell 
SH3 domains 
The Nef protein 
Nef is a 27-kDa protein encoded by human (HIV-l and 
HIV-2) and simian (SW) immunodeficiency viruses 
[14,15]. Although the exact role of Nef in the viral life 
cycle is controversial, Nef function is required for produc- 
tion of high viral loads of SIV and for progression of 
acquired immune deficiency syndrome (AIDS) in a 
Rhesus-monkey infection model [14,15]. More recently, an 
epidemiological study has documented a lack ofAIDS pro- 
gression in a small group of humans infected with Nef- 
defective HIV strains [16]. Functional studies of Nef 
suggests that it reduces the expression of the CD4 receptor 
on the T-cell surface and enhances the ability of HIV parti- 
cles to establish productive infections of primary (i.e., non- 
immortalized) cells, such as peripheral blood mononuclear 
cells [14,15]. CD4 is the high-affinity receptor used by 
HIV to attach to and enter cells. Downregulation of CD4 
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is expected to prevent additional cycles of infection (super- 
infection), a common survival strategy used by many 
viruses.To enhance viral infectivity, it seems either that Nef 
acts within cells that are producing virion particles (pro- 
ducer cells), or that it is carried along with the virion to act 
in the target cell, since de y1ovo synthesis of Nef is not 
required within target cells [ 1.51. 
The central region of Nef contains a conserved proline 
rich sequence with three potential PxxP motifs [4] 
(Fig. 4). Mutational analysis has indicated that the PxxP 
motifs are dispensable for downregulation of CD4, but 
one or more of them are required for enhancement of 
viral infectivity [4,17]. The mutant viruses used in these 
studies encoded Nef proteins in which all three conserved 
PxxP motifs were eliminated by alanine substitutions, so it 
was not possible to identify a single PxxP motif that was 
critical for this function. Saksela et al. [4] also showed that, 
in vitvo, wild-type Nef bound to SH3 domains from the 
St-c-related kinases Hck and Lyn, but not Fyn or Lck, and 
that this binding activity was dependent upon intact PxxP 
motifs. The interaction of Nef with the Lyn SH3 domain 
was sensitive to substitutions made at a position adjacent 
to one of the PxxP motifs, a position which varies 
between laboratory and patient-derived strains of HIV-l. 
Interaction between Nef and Hck or Lyn in viva has not 
been demonstrated and may be transient, or an SH3-con- 
taining host protein(s) that has not yet been identified may 
bind Nef with higher affinity. Other domains of Nef were 
also shown to be important for enhancement of viral 
infectivity [17], so Nef probably interacts with several 
types of host molecules in a cooperative manner. In this 
regard, it has been shown that a host-cell protein with 
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Fig. 4. Structures of microbial PxxP-containing proteins. 
Schematic representations of Nef, Tip, v-Fgr and YopH are shown. 
Locations of PxxP motifs are indicated by arrows. Other func- 
tional domains or regions of homology with other viral or cellular 
proteins are indicated by boxes. In Tip, CSKH indicates carboxy- 
terminal Src kinase homology region. In v-Fgr, p15 is derived 
from the viral p15 protein, actin corresponds to homology with 
cellular actin and kinase represents the tyrosine kinase domain. In 
YopH, the tyrosine phosphatase catalytic domain is indicated. 
The herpesvirus Tip protein 
Tip is a 40-kDa protein encoded by the first open reading 
frame of herpesvirus saimiri (HVS). This protein seems to 
be essential for HVS-mediated transformation of T cells 
from humans and New World primate species [ 18,19j. 
Analysis of HVS-transformed human T ceils reveals that 
Tip is associated with the Src-related tyrosine kinase Lck 
[19]. Moreover, when kinase reactions were performed on 
immunoprecipitated complexes of Tip and Lck, Tip 
became phosphorylated on tyrosine, suggesting that the 
viral protein is recognized as a substrate by the kinase. 
The 256-amino-acid Tip protein contains two regions 
related to host-cell signal transduction proteins: a short 
region related to a regulatory domain in Src kinases (the 
carboxy-terminal Src kinase homology region), and a 
PxxP motif related to a Src SH3-binding consensus motif 
(Fig. 4). Both regions were shown to be essential for inter- 
action of Tip with full length Lck in vitro and in trans- 
fected cell lines that overexpressed both proteins [20].The 
two regions seem to cooperate to enhance the aflinity of 
Tip binding to Lck, although it will be important to 
confirm these findings in HVS-transformed T cells and to 
demonstrate a role for the Lck SH3 domain in this inter- 
action. Lck has been shown to bind a number of different 
signal transduction proteins in T cells, including the CD4 
receptor. Interaction of Tip with Lck may modify the 
interaction of the kinase with the receptor, or other signal 
transduction proteins, leading to cellular immortalization 
and enhancement of viral replication. 
A family of PxxP-containing microbial proteins 
The development of consensus motifs for SH3 binding sites 
has facilitated the analysis of known SH3-binding proteins, 
and provided a tool to search for new SH3-binding proteins 
based on primary sequence alone [21,22]. For example, 
since it is known that Nef binds at least two Src-related SH3 
domains, it is possible to align the proline-rich region of Nef 
with a Src SH3-binding consensus motif (class II) based 
solely on the positions of conserved proline and arginine 
residues (Table 2). A similar alignment can be achieved with 
the proline-rich region of Tip, which presumably binds 
the SH3 domain of the Src-related kinase Lck (Table 2). 
Table 2. Alignment of SH3-binding motifs in microbial proteins. 
SH3-binding motif Sequence 
Src SH3 Class I consensu9 RXLPPLP 
v-Fgr 14-20 RPLPPLP 
Src SH3 Class II consensus XPPLPXR 
Nef 71-77 TPQVPLR 
Tip 176-l 82 TPPLPPR 
YopH 158-l 64 TPPLPPR 
“Consensus motifs are from Feng et a/. [6]. Critical prolines 
are shown in bold. SH3-binding motif in v-Fgr and its align- 
ment to Class I consensus is from Yu et al. [22]. SH3-binding 
motifs in Nef [4], Tip [20] and YopH (D. Black, personal com- 
munication) were aligned by eye using conserved proline 
and arginine residues. 
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Although this does not prove that Nef or Tip bind SH3 
domains in a class II orientation, it does provide a rational 
basis for mutational analysis of these SHS-binding proteins 
by single amino acid substitution. A comparative search of 
protein data bases with a consensus binding motif for the 
SH3 domain of phosphatidylinositol 3-kinase identified a 
potential SH3-binding site in the viral tyrosine kinase v-Fgr 
[22] (Table 2).W or k m our own laboratory has characterized 
an SH3 binding site in a bacterial tyrosine phosphatase, 
YopH, that is produced by pathogenic Yvrsinia species (D. 
Black et al., unpublished data) (Table 2).These results suggest 
the existence of a family of microbial proteins that interact 
with SH3 domains via PxxP motifs. In the case of v-Fgr and 
the Yevsinia tyrosine phosphatase, interaction with host cell 
SH3 domains could serve to localize these enzymes within 
cells, to regulate their activities, or to recruit substrates to 
their catalytic domains. 
Conclusions 
Significant advances have recently been made in our 
understanding of SH3 domains and their roles in signal 
transduction. It is now clear that SH3 domains mediate 
protein-protein interactions by binding to polyproline II 
helices that conform to the general consensus Pxxl?The 
rules that govern the selectivity and affinity of these inter- 
actions are being deciphered at the molecular and atomic 
levels. The modular nature of SH3 domains and PxxP- 
containing sequences allows for their insertion into pro- 
teins in many different positions and combinations. When 
combined with other types of protein domains, such as 
SH2, tyrosine kinase or tyrosine phosphatase domains, 
SH3 domains and PxxP motifs allow for the formation of 
highly specific, multiprotein signaling complexes. 
The exploitation of SH3-mediated interactions by patho- 
genic microorganisms follows a common theme in host- 
parasite interactions; microorganisms that adapt key 
elements of the host cell for their own devices gain a 
selective advantage. In the examples cited here, interactions 
mediated by SH3 domains seem to allow for the modula- 
tion of host cell signaling pathways in ways that enhance 
microbial replication and/or infectivity. The variation in 
SH3 selectivity by mutation that is apparent in two of the 
examples cited here (v-Crk and Nef) may be important in 
this regard. As an extension of these findings, it may be 
possible to design therapeutic reagents that treat infectious 
diseases by interfering with SH3-mediated interactions. By 
targeting the cellular counterpart of the microbial protein, 
it may be possible to tip the balance in favor of the host 
while problems associated with mutational variation on 
the part of the microbe would be avoided. 
Acknotvledge~lents: I thank D. Black for comments on the man- 
uscript and the National Institutes of Health (NIH First 
Award A135175) and the Pew Scholars Award for support. I 
regret that space limitations have not allowed me to include all 
primary references. 
References 























Biol. 3, 434-442. 
Cohen, C.B., Ren, R. & Baltimore, D. (1995). Modular binding 
domains in signal transduction proteins. Cell 80, 237-248. 
Feller, S.M., Ren, R., Hanafusa, H. & Baltimore, D. (1994). SH2 
and SH3 domains as molecular adhesives: the interactions of Crk 
and Abl. Trends Biochem. Sci. 19, 453-458. 
Saksela, K., Cheng, G. & Baltimore, D. (I 995). Proline-rich (PxxP) 
motifs in HIV-l Nef bind to SH3 domains of a subset of Src 
kinases and are required for the enhanced growth of Nef+ viruses 
but not for down-regulation of CD4. EMEOI. 14, 484-491. 
Kuriyan, j. & Cowburn, D. (1993). Structures of SH2 and SH3 
domains. Curr. @in. Struct. Biol. 3, 828-837. 
Feng, S., Chen, J.K., Yu, H., Simon, J.A. & Schreiber, S.L. (1994). 
Two binding orientations for peptides to the Src SH3 domain: 
development of a general model for SH3-ligand interactions. 
Science 266, 1241-l 247. 
Nojima, Y., et al., & Hirai, H. (1995). Integrin-mediated cell adhe- 
sion promotes tyrosine phosphorylation of pl30Cas, a Src homol- 
ogy 3-containing molecule having multiple Src homology 
2-binding motifs. /. Biol. Chem. 270, 15398-I 5402. 
Schumacher, C., Knudsen, B., Ohuchi, T., Di Fiore, P., Classman, 
R.H. & Hanafusa, H. (I 995). The SH3 domain of Crk binds specifi- 
cally to a conserved proline-rich motif in Epsl5 and Epsl5R. 1. 
Biol. Gem. 270, 15341-I 5347. 
Ren, R., Ye, Z.-S. & Baltimore, D. (1994). Abl protein-tyrosine 
kinase selects the Crk adapter as a substrate using SH3-binding 
sites. Genes Dev. 8, 783-795. 
Rosen, M.K., Yamazaki, T., Gish, G.D., Kay, C.M., Pawson, T. & 
Kay, L.E. (1995). Direct demonstration of an intramolecular SH2- 
phosphotyrosine interaction in the Crk protein. Nature 374, 
477-479. 
Matsuda, M., Reichman, C.T. & Hanafusa, H. (1992). Biological 
and biochemical activity of v-Crk chimeras containing the 
SH2/SH3 regions of phosphatidylinositol-specific phospholipase 
C-y and Src. /. Viral. 66, 1 15-l 21. 
Mayer, B.J. & Hanafusa, H. (1990). Mutagenic analysis of the v-crk 
oncogene: requirement for SH2 and SH3 domains and correlation 
between increased cellular phosphotyrosine and transformation. /. 
Viral. 64, 3581-3589. 
Wu, X., et a/., & Kuriyan, J. (I 995). Structural basis for the specific 
interaction of lysine-containing proline-rich peptides with the 
N-terminal SH3 domain of c-Crk. Structure 3, 215-226. 
Trono, D. (1995). HIV accessory proteins: leading roles for the 
supporting cast. Cell 82, 189-l 92. 
Miller, M.D., Feinberg, M.B. & Greene, W.C. (1994).The HIV-1 nef 
gene acts as a positive viral infectivity factor. Trends Micro&o/. 2, 
294-298. 
Deacon, N.J., et a/., & Mills, J. (1995). Genomic structure of an 
attenuated quasi species of HIV-l from a blood transfusion donor 
and recipients. Science 270, 988-991. 
Goldsmith, M.A., Warmerdam, M.T., Atchison, R.E., Miller, M.D. 
& Greene, W.C. (1995). Dissociation of CD4 downregulation and 
viral infectivity enhancement functions of human immunodefi- 
ciency virus type 1 Nef. 1. Viral. 69, 4112-412 1. 
Medveczky, M.M., Ceck, P., Sullivan, J.L., Serbousek, D., Djeu, 
J.Y. & Medveczky, P.G. (1993). IL-2 independent growth and cyto- 
toxicity of herpesvirus saimiri-infected human CD8 cells and 
involvement of two open reading frame sequences of the virus. 
Virology 196, 402-412. 
Biesinger, B., et al., & Broker, B.M. (1995). The product of 
herpesvirus saimiri open reading frame 1 (Tip) interacts with T 
cell-specific kinase p561ck in transformed cells. /. Biol. Chem. 
270, 4729-4734. 
Jung, J.U., et al., & Biesinger, B. (1995). Identification of 
Lck-binding elements in Tip of Herpesvirus saimiri. /. Biol. 
Chem. 270, 20660-20667. 
Ren, R., Mayer, B.J., Cicchetti, P. & Baltimore, D. (1993). 
Identification of a ten-amino acid proline-rich SH3 binding site. 
Science 259, 1157-l 161. 
Yu, H., Chen, J.K., Feng, S., Dalgarno, D.C., Brauer, A.W. & 
Schreiber, S.L. (1994). Structural basis for the binding of proline- 
rich peptides to SH3 domains. Cell 76, 933-945. 
Knudsen, B.S. & Hanafusa, H. (1995). Affinity and specificity 
requirements for the first Src homology 3 domain of the Crk 
proteins. EMBOJ. 14, 2191-2198. 
James Bliska, Department of Molecular Genetics and 
Microbiology, State University of New York at Stony 
Brook, Stony Brook, NY 11794, USA. 
